

Large Volume Parenteral (LVP) Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Large Volume Parenteral (LVP) market is experiencing significant growth, driven by the increasing demand for intravenous therapies. The global market size is projected to reach approximately $4 billion by 2026, reflecting a CAGR of over 8%. Factors such as rising chronic diseases and advancements in manufacturing technologies are propelling market expansion. Request Sample Report
◍ Baxter Healthcare
◍ Kelun Pharma
◍ B. Braun
◍ Fresenius
◍ Teva Pharmaceutical Industries
◍ Pfizer (Hospira)
◍ Ostuka Pharmaceutical
◍ CR Double-Crane
◍ Pisa
◍ Huaren
◍ Patheon
◍ Beximco Pharma
◍ Albert David
◍ PSI Ltd
◍ Ozon Pharmaceuticals
◍ BAG Healthcare
◍ BML Parenteral Drugs
The LVP market features key players like Baxter Healthcare, B. Braun, and Fresenius, focusing on innovation and production efficiency. Companies enhance market growth through strategic partnerships, expanding portfolios, and geographical reach. Annual sales revenue for some include Baxter (~$12 billion), Pfizer (~$51 billion), and Teva (~$16 billion).
Request Sample Report
Basic Infusion ◍ Therapeutic Infusion
◍ Nutritious Infusion
Request Sample Report
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
Request Sample Report
$ 13.90 Billion